Search terms
Results 1 - 8 of 8 - ordered by :

Wessel BROUWER (Amsterdam, NL) 14:00 P1690 Cardiac microvascular dysfunction in anderson-fabry disease: a dipyridamole PET-based study in a cohort of male and female patients Franco CECCHI (Florence, ...

Poster session 2: Hereditary cardiomyopathies

Date : 28/08/2011 Item size : 180000 bytes

14:00 P6144 Clinical characteristics and cardiac magnetic resonance for the patients received repeat percutaneous transluminal septal myocardial ablation in refractory hypertrophic obstructive ...

Poster session 7: Cardiomyopathies I

Date : 02/09/2014 Item size : 130412 bytes

14:00 P6183 Different response to adaptive servo-ventilation therapy according to the etiology of cardiomyopathy in patients with chronic heart failure Yasuo SUGANO (Osaka, JP) 14:00 P6184 Dried ...

Poster session 7: Cardiomyopathies IV

Date : 02/09/2014 Item size : 119107 bytes

Olga BLAGOVA (Moscov, Russian Federation) 14:00 P2801 Relationship of galectine-3 and NT-proBNP circulating levels with cardiac hypertrophy and function in patients with sarcomeric hypertrophic ...

Poster session 3: Cardiomyopathies

Date : 28/08/2016 Item size : 123577 bytes

Pasquale LOSURDO (Trieste, Italy) 08:30 P1623 High prevalence of N271I founder mutation in TNNT2 gene detected by NGS in a galician cohort cause hypertrophic cardiomyopathy associated with a benign ...

Poster session 2: Cardiomyopathies I

Date : 30/08/2015 Item size : 96557 bytes

11:00 P877 Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats Alyne MARQUES (Sao Paulo, Brazil) 11:00 P878 NT-proBNP: a potent parameter of ...

Poster session 1: Cardiomyopathies

Date : 27/08/2016 Item size : 121474 bytes

08:30 P787 Echocardiographic multi-parameter approach of right ventricular function as a prognostic factor in non-ischemic dilated cardiomyopathy Olivier HUTTIN (Nancy, FR) 08:30 P788 Prevalence of ...

Poster session Friday 7 December - AM: Cardiomyopathies

Date : 07/12/2012 Item size : 112454 bytes

14:00 P2634 Selumetinib, an oral anti-neoplastic drug, may prevent cardiac hypertrophy via targeting the ERK pathway Zhongxiu CHEN (Chengdu, China, People's Republic of) 14:00 P2635 Clinical profile ...

Poster session 3: Cardiomyopathies

Date : 30/08/2015 Item size : 70125 bytes